COMPANY PROFILE / #162
Isomorphic Labs
London, United KingdomVenture Capital-Backed
OVERVIEW
Operator of a digital biology company intended to redefine drug discovery with the power of artificial intelligence. The company reimagines the entire drug discovery process from first principles with an AI-first approach and ultimately aims to model and understand some fundamental mechanisms of life, enabling research institutions and healthcare organizations to improve healthcare outcomes by identifying better-targeted therapies with higher success rates and potentially lower costs.
已融资2,679.06
最新估值1,793.52
员工数371
成立年份2021
公司概况
- Companies
- Isomorphic Labs
- Description
- Operator of a digital biology company intended to redefine drug discovery with the power of artificial intelligence. The company reimagines the entire drug discovery process from first principles with an AI-first approach and ultimately aims to model and understand some fundamental mechanisms of life, enabling research institutions and healthcare organizations to improve healthcare outcomes by identifying better-targeted therapies with higher success rates and potentially lower costs.
- Website
- —
- HQ Location
- London, United Kingdom
- Year Founded
- 2021
- Keywords
- biotechnology research, digital biology, drug discovery process, fundamental data, generative ai, generative tech
- Competitors
- —
- Ownership Status
- Privately Held (backing)
- Company Financing Status
- Venture Capital-Backed
融资与估值
- Total Raised
- 2,679.06
- First Financing Date
- 31-Mar-2025
- First Financing Size
- 579.06
- First Financing Valuation
- 1,793.52
- Last Financing Date
- 03-Jun-2026
- Last Financing Deal Type
- Later Stage VC
- Last Financing Size
- —
- Last Financing Valuation
- —
- Last Financing Status
- —
- Last Known Valuation
- 1,793.52
- Last Known Valuation Date
- 31-Mar-2025
- Last Known Valuation Deal Type
- Early Stage VC
- Valuation Estimate
- —
- Valuation Estimate Growth Rate
- 119.34%
- Active Investors
- Alphabet, CapitalG, GV, MGX, Sovereign AI(Britain), Temasek Trust Capital, Thrive Capital
- # Active Investors
- —
- Acquirers
- —
团队与联系人
- Employees
- 371
- Employee Growth %
- —
- Employee History
- 2026: 371, 2025: 200, 2024: 90, 2023: 77, 2022: 43, 2021: 2
- Primary Contact
- Demis Hassabis
- Primary Contact Title
- Founder & Chief Executive Officer
- Primary Contact Email
- demis@isomorphiclabs.com
- Primary Contact Phone
- —
增长与经营
- Revenue
- —
- Revenue Growth %
- —
- Growth Rate
- 1.54%
- Growth Rate % Change
- —
- Growth Rate Percentile
- 99
- Size Multiple
- 60.03x
- Size Multiple % Change
- 0.00%
- Size Multiple Change
- 0.00x
- Size Multiple Percentile
- —
- Majestic Referring Domains
- 1,916
- SimilarWeb Unique Visitors
- 15,767
- SimilarWeb Unique Visitors Change
- —
- SimilarWeb Growth Rate
- —
- SimilarWeb Growth Rate Percentile
- —
- Success Probability Over Time – 1 Year
- 15%
- Success Probability Over Time – 3 Year
- 37%
- Success Probability Over Time – 5 Year
- 47%
记录来源：public.companies · 原始序号 #162 · 所有字段均按数据库原值展示。